Literature DB >> 33673831

Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Iwein Gyselinck1, Laurens Liesenborghs2, Ewout Landeloos2, Ann Belmans3, Geert Verbeke3, Peter Verhamme2, Robin Vos2, W Janssens2.   

Abstract

Entities:  

Year:  2021        PMID： 33673831     DOI： 10.1186/s13063-021-05153-4

Source DB:  PubMed          Journal:  Trials        ISSN： 1745-6215            Impact factor:   2.279


× No keyword cloud information.
  1 in total

1.  Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.

Authors:  Iwein Gyselinck; Laurens Liesenborghs; Ewout Landeloos; Ann Belmans; Geert Verbeke; Peter Verhamme; Robin Vos; W Janssens
Journal:  Trials       Date:  2021-02-09       Impact factor: 2.728
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.